Investing.com - Abbott Labs (NYSE:ABT) reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $1.32 on revenue of $11.47B. Analysts polled by Investing.com anticipated EPS of $1.21 on revenue of $10.66B.
Abbott Labs shares are down 12% from the beginning of the year, still down 13.56% from its 52 week high of $142.60 set on December 27, 2021. They are under-performing the S&P 500 which is down 8.6% from the start of the year.
Abbott Labs shares lost 0.32% in pre-market trade following the report.
Abbott Labs follows other major Healthcare sector earnings this month
Abbott Labs's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar